Siegfried Holding
Philippe Ogay possesses extensive experience in the field of chemistry, currently serving as a Production Chemist and Project Coordinator at Siegfried - Expect More since October 2015. From October 2001 to the present, Philippe has held positions as both Production Chemist and R+D Chemist at BASF. Prior to this, Philippe was employed as an R+D Chemist in a post-doctoral role at Roche Pharmaceuticals from July 2000 to September 2001. Philippe holds a PhD in Chemistry from the University of Lausanne - UNIL, obtained from 1990 to 1995, and has further educational background from Champittet and the University of Bern.
This person is not in the org chart
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.